PCSK9 Forum is made possible thanks to support from AstraZeneca, LIB Therapeutics, Novartis and Sanofi, all of whom have no influence or control of editorial content. More information is available here »

Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

8th Closed Scientific Expert Meeting of the Editorial Board

4th May 2018, Lisbon, Portugal (Educational supporters)

Lp(a) as a cardiovascular risk factor – Is lowering Lp(a) beneficial when LDL is low?

Lp(a) as a cardiovascular risk factor – Is lowering Lp(a) beneficial when LDL is low?

Reports from the 8th Expert Meeting of PCSK9 Forum Dr Pia Kamstrup

read more »
Posted on 28 June 2018 | Posted by Pia Kamstrup | Posted in Webcasts, 8th Closed Scientific Expert Meeting of the Editorial Board
Low LDL-C and cognitive function: Benefit or harm?

Low LDL-C and cognitive function: Benefit or harm?

Reports from the 8th Expert Meeting of PCSK9 Forum Professor Francois Mach

read more »
Posted on 20 June 2018 | Posted by Francois Mach | Posted in Webcasts, 8th Closed Scientific Expert Meeting of the Editorial Board
Do low LDL-C levels enhance diabetes risk?

Do low LDL-C levels enhance diabetes risk?

Reports from the 8th Expert Meeting of PCSK9 Forum Professor Dirk Müller-Wieland

read more »
Posted on 19 June 2018 | Posted by Dirk Müller-Wieland | Posted in Webcasts, 8th Closed Scientific Expert Meeting of the Editorial Board
Do low LDL-C levels achieved with statin therapy increase the risk for diabetes mellitus?

Do low LDL-C levels achieved with statin therapy increase the risk for diabetes mellitus?

Reports from the 8th Expert Meeting of PCSK9 Forum Professor Henry Ginsberg

read more »
Posted on 19 June 2018 | Posted by Henry Ginsberg | Posted in Webcasts, 8th Closed Scientific Expert Meeting of the Editorial Board
ODESSEY OUTCOMES Trial: Topline results

ODESSEY OUTCOMES Trial: Topline results

Reports from the 8th Expert Meeting of PCSK9 Forum Professor J Wouter Jukema

read more »
Posted on 12 June 2018 | Posted by J Wouter Jukema | Posted in Webcasts, 8th Closed Scientific Expert Meeting of the Editorial Board
Inclisiran and the ORION Project

Inclisiran and the ORION Project

Reports from the 8th Expert Meeting of PCSK9 Forum Frederick Raal

read more »
Posted on 12 June 2018 | Posted by Frederick J. Raal | Posted in Webcasts, 8th Closed Scientific Expert Meeting of the Editorial Board
FOURIER: Timing is everything

FOURIER: Timing is everything

Reports from the 8th Expert Meeting of PCSK9 Forum Professor Gaetano M De Ferrari

read more »
Posted on 12 June 2018 | Posted by Gaetano De Ferrari | Posted in Webcasts, 8th Closed Scientific Expert Meeting of the Editorial Board

About PCSK9 Education and Research Forum

PCSK9 Education and Research Forum is a not-for-profit organisation established by leading researchers in the fields of atherosclerosis, lipids and cardiovascular disease. Our mission is to raise awareness and knowledge of the significant role played by PCSK9 in lipid metabolism and its value as a novel therapeutic target.

Editorial Policy

Unless otherwise indicated, opinions expressed in the PCSK9 Education and Research Forum are those of the contributors. All patients should discuss their medication with their healthcare professional. Although every effort is made to ensure accuracy and avoid mistakes, no liability on the part of the PCSK9 Forum, the editors or the editorial board is accepted for the consequences of any misleading or inaccurate information.
Educational Partners and Supporters
AstraZeneca

AstraZeneca has provided a grant towards this independent project and has had no involvement in its creation or organisation

LIB Therapeutics

Novartis

Sanofi

© Copyright 2025 PCSK9 Forum. All rights reserved